Literature DB >> 31342053

Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome.

Seongman Bae1, Hye Jeon Hwang2, Mi Young Kim2, Min Jae Kim1, Yong Pil Chong1, Sang-Oh Lee1, Sang-Ho Choi1, Yang Soo Kim1, Jun Hee Woo1, Sung-Han Kim1.   

Abstract

Sixteen of 45 patients with severe fever with thrombocytopenia (36%) were admitted to an intensive care unit; 9 (56%) developed invasive pulmonary aspergillosis (IPA) within a median of 8 days (range, 2-11). Mortality was higher in the IPA vs non-IPA patients and in those without vs with antifungal therapy.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  invasive pulmonary aspergillosis; severe fever with thrombocytopenia syndrome; severe fever with thrombocytopenia syndrome virus

Mesh：

Substances：

Year:  2020        PMID： 31342053     DOI： 10.1093/cid/ciz673

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  7 in total

Review 1.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  Proven Nasal and Pulmonary Aspergillosis in Patient with Severe Fever with Thrombocytopenia Syndrome.

Authors:  Gil Myeong Seong; Chang Lim Hyun; Suk Won Chang; Jeong Rae Yoo
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-03-30

3.  Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case-Control Study.

Authors:  Takeshi Kawaguchi; Kunihiko Umekita; Atsushi Yamanaka; Seiichiro Hara; Tetsuro Yamaguchi; Eisuke Inoue; Akihiko Okayama
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

4.  Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Lifen Hu; Qinxiang Kong; Chengcheng Yue; Xihai Xu; Lingling Xia; Tingting Bian; Yanyan Liu; Hui Zhang; Xuejiao Ma; Huafa Yin; Qiulin Sun; Yufeng Gao; Ying Ye; Jiabin Li
Journal:  Front Immunol       Date:  2021-05-07       Impact factor: 7.561

5.  Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea.

Authors:  Ji-Soo Kwon; Sol Jin; Ji-Yeun Kim; Sang-Hyun Ra; Taeeun Kim; Se-Yoon Park; Min-Chul Kim; Seong-Yeon Park; Dasarang Kim; Hye-Hee Cha; Hyun-Jung Lee; Min-Jae Kim; Yong-Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang-Soo Kim; Keun-Hwa Lee; Sun-Ho Kee; Sung-Han Kim
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

6.  Clinical Differentiation of Severe Fever with Thrombocytopenia Syndrome from Japanese Spotted Fever.

Authors:  Nana Nakada; Kazuko Yamamoto; Moe Tanaka; Hiroki Ashizawa; Masataka Yoshida; Asuka Umemura; Yuichi Fukuda; Shungo Katoh; Makoto Sumiyoshi; Satoshi Mihara; Tsutomu Kobayashi; Yuya Ito; Nobuyuki Ashizawa; Kazuaki Takeda; Shotaro Ide; Naoki Iwanaga; Takahiro Takazono; Masato Tashiro; Takeshi Tanaka; Seiko Nakamichi; Konosuke Morimoto; Koya Ariyoshi; Kouichi Morita; Shintaro Kurihara; Katsunori Yanagihara; Akitsugu Furumoto; Koichi Izumikawa; Hiroshi Mukae
Journal:  Viruses       Date:  2022-08-18       Impact factor: 5.818

Review 7.  Clinical Update of Severe Fever with Thrombocytopenia Syndrome.

Authors:  Jun-Won Seo; Dayoung Kim; Nara Yun; Dong-Min Kim
Journal:  Viruses       Date:  2021-06-23       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.